MedPath

Optimization of Insomnia Treatment in Primary Care

Not Applicable
Conditions
Insomnia Disorder
Interventions
Drug: Hypnotics
Behavioral: Online CBT
Behavioral: Face-to-face CBT
Registration Number
NCT03633305
Lead Sponsor
Laval University
Brief Summary

The primary objective of this pragmatic clinical trial is to evaluate the efficacy, feasibility, and adaptability of pharmacological and non-pharmacological treatments for insomnia disorder, delivered in primary care clinics. The second objective is to evaluate the efficacy of a sequential (stepped care) approach for persistent insomnia.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Aged 18 years or over
  • Meeting criteria for insomnia disorder
  • Registered patient at one of the primary care clinics participating in the study
  • Fluent in French
  • Computer and internet access
Exclusion Criteria
  • Unstable or untreated psychiatric disorder
  • Lifetime psychotic or bipolar disorder
  • Current suicide risk
  • Progressive or unstable medical disorder
  • Untreated sleep disorder other than insomnia
  • Use of medication altering sleep
  • Irregular or atypical sleep-wake schedule
  • Current or planned pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Treatment as usualHypnoticsHypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks
Online cognitive behavior therapyOnline CBTOnline CBT- Internet self-help program for insomnia with 6 cores
Treatment as usual + Online CBTHypnoticsHypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks Online CBT- Internet self-help program for insomnia with 6 cores
Treatment as usual + Online CBTOnline CBTHypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks Online CBT- Internet self-help program for insomnia with 6 cores
MedicationHypnoticsHypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks (arms 1, 3, 4)
In-person cognitive behavior therapyFace-to-face CBTFace-to-face CBT- Face-to-face therapy with 3 to 4 individual sessions in a period of 6 to 8 weeks.
Primary Outcome Measures
NameTimeMethod
Remission of insomniaPost-2 (after 6-week treatment phase 2)

Insomnia Severity Index score (average of two consecutive weeks \< 8, with none \> 10)

Secondary Outcome Measures
NameTimeMethod
Total sleep time from sleep diaryPost-2 (after 6-week treatment phase 2)

Mean total sleep time per night in minutes from sleep diary

Sleep efficiency from actigraphyPost-2 (after 6-week treatment phase 2)

Mean sleep efficiency in percentage (total sleep time divided by time spent in bed, multiplied by 100) from actigraphy

DepressionPost-2 (after 6-week treatment phase 2)

Patient Health Questionnaire (PHQ-9)

AnxietyPost-2 (after 6-week treatment phase 2)

Generalized Anxiety Disorder 7-item (GAD-7)

DisabilityPost-2 (after 6-week treatment phase 2)

Work and Social Adjustment Scale (5-item scale scale assessing functional impact of insomnia; total score ranging from 0 to 40, higher scores indicating greater disability)

Medication usePost-2 (after 6-week treatment phase 2)

Frequency of use (number of nights/week)

Total wake time from sleep diaryPost-2 (after 6-week treatment phase 2)

Mean total wake time (combining sleep onset latency, wake after sleep onset, and duration of early morning awakening) in minutes from sleep diary

Sleep efficiency from sleep diaryPost-2 (after 6-week treatment phase 2)

Mean sleep efficiency in percentage (total sleep time divided by time spent in bed, multiplied by 100) from sleep diary

Total sleep time from actigraphyPost-2 (after 6-week treatment phase 2)

Mean total sleep time per night in minutes from actigraphy

Total wake time from actigraphyPost-2 (after 6-week treatment phase 2)

Mean total wake time (combining sleep onset latency, wake after sleep onset, and duration of early morning awakening) in minutes from actigraphy

FatiguePost-2 (after 6-week treatment phase 2)

Flinders Fatigue Scale (7-item self-report scale measuring fatigue over the past two weeks; total score ranges from 0 to 31, higher scores indicating greater fatigue)

Trial Locations

Locations (1)

Laval University

🇨🇦

Quebec City, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath